全文获取类型
收费全文 | 34932篇 |
免费 | 5390篇 |
国内免费 | 838篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 381篇 |
妇产科学 | 326篇 |
基础医学 | 3719篇 |
口腔科学 | 32篇 |
临床医学 | 3006篇 |
内科学 | 881篇 |
皮肤病学 | 120篇 |
神经病学 | 64篇 |
特种医学 | 1454篇 |
外国民族医学 | 74篇 |
外科学 | 4678篇 |
综合类 | 4550篇 |
现状与发展 | 6篇 |
一般理论 | 1篇 |
预防医学 | 1552篇 |
眼科学 | 35篇 |
药学 | 1978篇 |
27篇 | |
中国医学 | 627篇 |
肿瘤学 | 17640篇 |
出版年
2024年 | 134篇 |
2023年 | 578篇 |
2022年 | 1256篇 |
2021年 | 1839篇 |
2020年 | 1694篇 |
2019年 | 1499篇 |
2018年 | 1409篇 |
2017年 | 1466篇 |
2016年 | 1593篇 |
2015年 | 1955篇 |
2014年 | 2330篇 |
2013年 | 2555篇 |
2012年 | 1964篇 |
2011年 | 2096篇 |
2010年 | 1589篇 |
2009年 | 1511篇 |
2008年 | 1535篇 |
2007年 | 1646篇 |
2006年 | 1678篇 |
2005年 | 1516篇 |
2004年 | 1253篇 |
2003年 | 1208篇 |
2002年 | 1012篇 |
2001年 | 899篇 |
2000年 | 709篇 |
1999年 | 620篇 |
1998年 | 494篇 |
1997年 | 473篇 |
1996年 | 387篇 |
1995年 | 326篇 |
1994年 | 239篇 |
1993年 | 215篇 |
1992年 | 182篇 |
1991年 | 176篇 |
1990年 | 127篇 |
1989年 | 114篇 |
1988年 | 111篇 |
1987年 | 100篇 |
1986年 | 95篇 |
1985年 | 117篇 |
1984年 | 88篇 |
1983年 | 60篇 |
1982年 | 76篇 |
1981年 | 81篇 |
1980年 | 40篇 |
1979年 | 39篇 |
1978年 | 28篇 |
1977年 | 19篇 |
1976年 | 18篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
4.
5.
《Diagnostic Histopathology》2022,28(3):156-160
Breast core biopsies are a standard component of the triple approach that includes clinical examination, imaging and tissue sampling. Conventional cores, diagnostic vacuum assisted biopsy and vacuum assisted excisions are established methods for sampling and managing breast lesions. It is important to be aware of the potential pitfalls in the technical handling and interpretation of the limited core biopsy samples. Here, we present a clinically oriented, well illustrated overview of the common diagnostic pitfalls based on the author's diagnostic and second opinion practice, emphasize the value of clinicopathological correlation and provide histological tips and clues with useful immunohistochemistry to aid the reporting pathologists in their daily interpretation of breast core biopsies. 相似文献
6.
7.
8.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
9.
10.
三阴性乳腺癌(triple negative breast cancer,TNBC)是雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)及人类表皮生长因子受体(human epidermal growth factor-2,HER-2)均不表达的乳腺癌。按其功能特征可归纳为5类分子分型:以DNA修复缺陷或生长因子为途径的基底细胞样三阴性乳腺癌;以上皮-间充质转化和肿瘤干细胞为特征的间质样三阴性乳腺癌;免疫调节型三阴性乳腺癌;雄激素受体过表达的管腔/分泌型三阴性乳腺癌;HER-2富集型三阴性乳腺癌。三阴性乳腺癌恶性程度高且异型性较大,其治疗困难且预后较差,内分泌治疗及靶向治疗不敏感。目前很多学者对于三阴性乳腺癌的治疗各有研究,并有临床试验证实下述治疗有效。 相似文献